BTG's varicose vein treatment passes US trials
Pharmaceuticals group BTG says Varisolve, a new treatment for varicose veins, has been successful in VANISH-1, the second and final phase III trial in the US.
Pharmaceuticals group BTG says Varisolve, a new treatment for varicose veins, has been successful in VANISH-1, the second and final phase III trial in the US.
The microfoam, Varisolve, aims to treat the not-easy-to-pronounce "saphenofemoral junction incompetence" which can lead to varicose symptoms.
The success of the VANISH-1 trial follows the positive outcome from VANISH-2, the first pivotal Phase III trial, the results of which were announced at the end of January.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Investigator Dr Ted King, the National Medical Director of Vein Clinics of America, said: "VANISH-1 and VANISH-2 are extremely rigorous trials that have both shown clear benefits ... in patients with symptomatic varicose veins, as assessed by the patients and their treating physicians and in a randomised, controlled manner."
Based on the successful outcome of these two pivotal Phase III trials, BTG intends to submit a New Drug Application this year in the US, seeking approval of Varisolve (polidocanol endovenous microfoam, or PEM) as a comprehensive treatment for symptoms and appearance of varicose veins.
The market wasn't terribly impressed, at 08:11 the stock had fallen 0.5% although since the start of the year the shares have gained 22%.
BS
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
-
Inheritance tax bills exceed £500,000 for almost 10% of estates
Thousands of estates have had to pay a six figure inheritance tax bill – and the issue looks set to worsen.
-
Can gold protect you against inflation?
Inflation is on the rise in the UK. Could investing in gold protect your portfolio against rising prices?